Related Experiment Videos

PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success

Hilda Wong1, Thomas Yau, Pierre Chan

  • 1Division of Hematology/Oncology, Department of Medicine, Queen Mary Hospital, Hong Kong, Hong Kong.

Pathology Oncology Research : POR
|August 21, 2009
PubMed

Insights

Proton-pump inhibitors (PPIs) can mask symptoms of hypergastrinemia, delaying diagnosis of neuroendocrine tumors. Measuring serum gastrin is recommended for persistent dyspepsia unresponsive to PPIs without H. pylori.

Area of Science:

  • Oncology
  • Endocrinology
  • Gastroenterology

Background:

  • Functional neuroendocrine tumors (NETs) are often low-grade, curable with early surgical detection.
  • Neuropeptide hypersecretion syndromes can aid in early NET detection.
  • Hypergastrinemia-induced peptic symptoms are often treated with proton-pump inhibitors (PPIs).

Observation:

  • A clinical case highlights a diagnostic delay exceeding 10 years for a NET.
  • Delayed diagnosis was partly due to symptom masking by continuous omeprazole (a PPI) use.
  • This suggests a potential clinical syndrome of PPI-dependent dyspepsia masking underlying conditions.

Findings:

  • Proposes diagnostic criteria for a new clinical syndrome where PPIs mask NET symptoms.
  • Highlights the risk of delayed diagnosis in patients with persistent dyspepsia on PPIs.
  • Identifies hypergastrinemia as a key factor in PPI-dependent dyspepsia.

Implications:

  • Recommends routine serum gastrin level measurement in specific dyspepsia cases.
  • Aims to improve early detection of functional neuroendocrine tumors.
  • Emphasizes the need for physician awareness regarding PPI-induced symptom masking in NET diagnosis.

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...